Please assess the completion status of the following clinical trial:

Trial Title: A Study to Assess the Safety and Effectiveness of Durogesic (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Long-term Narcotic Pain Relief Therapy

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients with a confirmed malignancy (whose pain is judged by the investigator to be caused by the malignancy), or patients with other life-threatening/terminal disease whose pain requires treatment with strong opioid analgesia~* requiring treatment of pain with a strong opioid and who are expected to continue to require treatment with a strong opioid for the duration of the study~* receiving a stable dose of immediate-release oral morphine or sustained-release morphine (minimum daily dose of morphine is 30 mg/day) for at least 48 hours immediately prior to entry into the study~Exclusion Criteria:~* Patients with a history of allergy or hypersensitivity to fentanyl or morphine~* have active skin disease that precludes application of Durogesic® or which may affect the absorption of fentanyl~* have a clinical condition that in the investigator's judgment prevents participation in the study~* have participated in any other drug trial relating to pain control within one month of study entry~* currently participating in any other study or research project which would interfere with this trial.

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).